Publikationen 2010
Grgic A, Nestle U, Scheidhauer K, Puskas C, Ballek E, Hohloch K, Schubert J, König J, Pinkert J, Truemper L, Hellwig D, Kirsch CM.
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.
PMID: 21057722 [PubMed - in process]
Link zur Website
Hellwig D., Ketter R., Romeike B.F., Schaefer A., Farmakis G., Grgic A., Moringlane J.R., Steudel W.I., Kirsch C.M., Samnick S.
Prospective study of p-[123]iodo-L-phanylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2403-4.
Link zur Website
Hellwig D., Krause B.-J., Schirrmeister H., Freesmeyer M.
Skelettdiagnostik mittels 18F-Natriumfluorid-PET und -PET/CT
DGN-Leitlinie
Nuklearmed-Nucl med 49(5) 195-201, Jahr 2010
Morschhauser F., Kraeber-Bodéré F., Wegener W.A., Harousseau J., Petillon M., Huglo D., Trümper L.H., Meller J., Pfreundschuh M., Kirsch C.-M., Naumann R., Kropp J., Horne H., Teoh N., Le Gouill S., Bodet-Milin C., Chatal J.-F., Goldenberg D.M.
High rates of durable responses with Anti-CD22 fractionated radioimmunotherapy : results of a multicenter, phase I/II study in Non-Hodgkin`s lymphoma
Journal of clinical oncology, 26.7.2010
Geworsky L., Schaefer A., Knoop B.O., Pinkert J., Kirsch C.M.,
Physical aspects of scintigraphy-based dosimetry für nuclear medicine therapy
Nuklearmedizin 2010;49:85-95; PMID: 20505893
Link zur Website
Riemann B, Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, Sauerland C, Frankewitsch T, Schober O, MSDS study group.
Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial.
Nuklearmedizin 2010;49(3):79-84, PMID: 20505894 [PubMed - in process]
Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lübbe AS, Reinhold T, Späth-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeböller H, Böcking A, Bohle RM, Brüske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gütz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hübner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Müller KM, Müller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rübe C, Schmittel A, Schönfeld N, Schütte W, Serke M, Stamatis G, Steingräber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C, Worth H
Prevention, diagnosis, therapy and follow-up lung cancer
Pneumologie. 2010 Mar;64 Suppl 2:e1-164. Epub 2010 Mar 9. German. No abstract available. PMID: 20217630
Grgic A.,Yüksel Y., Gröschel A., Schäfers H.J., Sybrecht G.W., Kirsch C.M., Hellwig D.
Risk stratification of solitary pulmonary nodule by means of PET using 18F-Fluordeoxyglucose and SUV quantification
Eur J Nucl Med Mol Imaging ( in press )
Link zur Website
Kotzerke J, Oehme L, Lindner O, Hellwig D
Positron emission tomography 2008 in Germany - results of the query and current status
Nuklearmed-Nucl med 49(2) 58-64, Jahr 2010
Link zur Website
Torwarth D, Schaefer A,
Functional target volume delineation for radiation therapy in the basis of positron emission tomography and the correlation with histopathology
J Nucl Med Mol Imaging 54, 490 -99, Jahr 2010
